ETHACRYNIC Drug Patent Profile
✉ Email this page to a colleague
When do Ethacrynic patents expire, and what generic alternatives are available?
Ethacrynic is a drug marketed by Adaptis, Agnitio, Alvogen, Amneal Pharms Co, Chartwell Rx, Hikma, Lupin, Ph Health, Sciegen Pharms, and Upsher Smith Labs. and is included in ten NDAs.
The generic ingredient in ETHACRYNIC is ethacrynic acid. There are thirteen drug master file entries for this compound. Ten suppliers are listed for this compound. Additional details are available on the ethacrynic acid profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Ethacrynic
A generic version of ETHACRYNIC was approved as ethacrynic acid by ADAPTIS on June 30th, 2016.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for ETHACRYNIC?
- What are the global sales for ETHACRYNIC?
- What is Average Wholesale Price for ETHACRYNIC?
Summary for ETHACRYNIC
| US Patents: | 0 |
| Applicants: | 10 |
| NDAs: | 10 |
| Drug Prices: | Drug price information for ETHACRYNIC |
| DailyMed Link: | ETHACRYNIC at DailyMed |
US Patents and Regulatory Information for ETHACRYNIC
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Adaptis | ETHACRYNIC ACID | ethacrynic acid | TABLET;ORAL | 205609-001 | Jun 30, 2016 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Lupin | ETHACRYNIC ACID | ethacrynic acid | TABLET;ORAL | 211719-001 | Sep 6, 2019 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Amneal Pharms Co | ETHACRYNIC ACID | ethacrynic acid | TABLET;ORAL | 208805-001 | May 8, 2018 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Ph Health | ETHACRYNIC ACID | ethacrynic acid | TABLET;ORAL | 208501-001 | Jul 21, 2017 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
